Loading...
•
Mar 31, 2024
Bausch Health Q1 2024 Earnings Report
Bausch Health reported a revenue increase of 11% and solid first-quarter performance, marking the fourth consecutive quarter of year-over-year growth in revenues and adjusted EBITDA.
Key Takeaways
Bausch Health announced strong first quarter 2024 results with revenues of $2.15 billion, up 11% on a reported basis and 8% organically. All segments showed year-over-year revenue growth. The company reaffirmed its full-year revenue and adjusted EBITDA guidance.
First quarter revenues reached $2.15 billion, an 11% increase reported and 8% organically.
All segments experienced year-over-year revenue growth on both reported and organic bases.
GAAP Net Loss Attributable to Bausch Health Companies Inc. was $64 Million.
Adjusted EBITDA Attributable to Bausch Health Companies Inc. (non-GAAP) was $665 Million, a 13% increase.
Revenue by Segment
Forward Guidance
The Company reaffirmed its full-year revenue and Adjusted EBITDA (non-GAAP) guidance.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...